Model Portfolios | Institutional | News | Contact

AGNG

Aging Population ETF

Reasons to Consider AGNG

Long-Term Growth Potential

Humans are living longer than ever, with forecasts suggesting the global population of adults age 60+ could double to more than 2bn by 2050.¹

Demographics Drive Consumption

With a ballooning senior population, particularly in western countries, we expect to see waves of innovation catering to their distinct consumer preferences.

Unconstrained Approach

The Aging Population theme is a global trend, affecting a wide range of industries. AGNG invests accordingly, offering exposure to companies regardless of sector or geographic classification.

¹WHO, Oct 2021

Key Information As of 11/28/23

Inception Date	05/09/16
Total Expense Ratio	0.50%
Net Assets	$53.41 million
NAV	$26.57
Fact Sheet	View the document

ETF Summary

The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

ETF Objective

The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.

Trading Details As of 11/28/23

Ticker	AGNG
Bloomberg Index Ticker	ILNGRNT
CUSIP	37954Y772
ISIN	US37954Y7720
Primary Exchange	Nasdaq
Shares Outstanding	2,010,000
Number of Holdings	93
30-Day Median Bid-Ask Spread	0.35%

Distributions As of 11/28/23

30-Day SEC Yield	1.08%
Distribution Frequency	Semi-Annually

ETF Prices As of 11/28/23

NAV	$26.57	Daily Change	-$0.06	-0.23%
Market Price	$26.51	Daily Change	-$0.10	-0.38%

As of recent (09/30/23) As of recent (09/30/23)	Fund NAV	Market Price	Index
1 Year	11.72%	11.43%	12.03%
3 Years	1.24%	1.12%	1.47%
5 Years	3.89%	3.71%	4.10%
Since Inception	8.36%	8.61%	8.64%
1 Year	0.55%	0.72%	0.82%
3 Years	1.24%	1.24%	1.45%
5 Years	5.78%	5.68%	6.00%
Since Inception	7.60%	7.89%	7.88%
Year-to-Date	0.05%	-0.14%	0.29%
1 Month	-4.46%	-4.55%	-4.43%
3 Months	-6.11%	-6.44%	-6.00%
Since Inception	81.16%	84.28%	84.66%
Year-to-Date	-4.43%	-4.32%	-4.21%
1 Month	-4.48%	-4.19%	-4.48%
3 Months	-10.99%	-10.65%	-10.93%
Since Inception	73.04%	76.55%	76.38%

Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.

Net Assets (%)	Ticker	Name	SEDOL	Market Price ($)	Shares Held	Market Value ($)
5.02	LLY	ELI LILLY & CO	2516152	591.60	4,485	2,653,326.00
4.31	4519 JP	CHUGAI PHARMA CO	6196408	33.91	67,164	2,277,253.83
3.89	NOVOB DC	NOVO NORDISK A/S-B	BP6KMJ1	101.31	20,308	2,057,373.28
3.82	WELL	WELLTOWER INC	BYVYHH4	89.31	22,639	2,021,889.09
3.40	BSX	BOSTON SCIENTIFIC CORP	2113434	54.93	32,755	1,799,232.15
3.36	AMGN	AMGEN INC	2023607	265.52	6,690	1,776,328.80
3.31	SGEN	SEAGEN INC	BLPK4D2	214.16	8,179	1,751,614.64
3.26	ALC SW	ALCON INC	BJT1GR5	73.77	23,395	1,725,958.90
3.20	SYK	STRYKER CORP	2853688	292.04	5,785	1,689,451.40
3.08	REGN	REGENERON PHARMACEUTICALS	2730190	801.14	2,032	1,627,916.48
3.07	DXCM	DEXCOM INC	B0796X4	112.20	14,463	1,622,748.60
3.07	MDT	MEDTRONIC PLC	BTN1Y11	78.63	20,611	1,620,642.93
2.90	JNJ	JOHNSON & JOHNSON	2475833	151.63	10,123	1,534,950.49
2.70	ABBV	ABBVIE INC	B92SR70	138.08	10,335	1,427,056.80
2.69	AZN	ASTRAZENECA PLC-SPONS ADR	2989044	63.30	22,488	1,423,490.40
2.52	EW	EDWARDS LIFESCIENCES CORP	2567116	67.10	19,862	1,332,740.20
2.51	BIIB	BIOGEN INC	2455965	227.41	5,827	1,325,118.07
2.22	RO SW	ROCHE HOLDING AG-BR	7108918	281.66	4,168	1,173,977.57
2.21	BMY	BRISTOL-MYERS SQUIBB CO	2126335	48.92	23,885	1,168,454.20
1.77	4543 JP	TERUMO CORP	6885074	32.17	29,000	933,067.35
1.76	ZBH	ZIMMER BIOMET HO	2783815	113.09	8,217	929,260.53
1.62	4503 JP	ASTELLAS PHARMA INC	6985383	12.19	70,183	855,456.16
1.60	STMN SW	STRAUMANN HOLDING AG-REG	BQ7ZV06	136.39	6,210	846,994.93
1.48	GMAB DC	GENMAB A/S	4595739	303.53	2,575	781,584.35
1.43	BGNE	BEIGENE LTD-ADR	BYYWPW6	184.84	4,092	756,365.28
1.39	068270 KS	CELLTRION INC	B0C5YV1	127.54	5,742	732,326.04
1.35	VTR	VENTAS INC	2927925	45.55	15,658	713,221.90
1.26	SOON SW	SONOVA HOLDING AG-REG	7156036	280.30	2,382	667,670.52
1.07	UCB BB	UCB SA	5596991	74.41	7,567	563,042.10
0.96	PODD	INSULET CORP	B1XGNW4	185.72	2,724	505,901.28
0.88	FME GR	FRESENIUS MEDICA	5129074	40.97	11,387	466,528.64
0.88	3692 HK	HANSOH PHARMACEU	BJYKB72	2.00	232,643	466,013.96
0.87	INCY	INCYTE CORP	2471950	52.70	8,688	457,857.60
0.85	EXAS	EXACT SCIENCES CORP	2719951	64.97	6,946	451,281.62
0.84	COH AU	COCHLEAR LTD	6211798	173.52	2,566	445,242.79
0.83	SN/ LN	SMITH & NEPHEW PLC	0922320	12.95	34,059	441,023.21
0.80	NBIX	NEUROCRINE BIOSC	2623911	112.84	3,762	424,504.08
0.80	UTHR	UNITED THERAPEUTICS CORP	2430412	230.39	1,827	420,922.53
0.77	TFX	TELEFLEX INC	2881407	219.83	1,853	407,344.99
0.71	DEMANT DC	DEMANT A/S	BZ01RF1	41.83	8,995	376,218.49
0.67	DVA	DAVITA INC	2898087	99.67	3,543	353,130.81
0.55	OHI	OMEGA HEALTHCARE	2043274	31.75	9,178	291,401.50
0.52	AMP IM	AMPLIFON SPA	B14NJ71	30.97	8,842	273,806.25
0.51	EXEL	EXELIXIS INC	2576941	21.05	12,701	267,356.05
0.46	BPMC	BLUEPRINT MEDICINES CORP	BWY52P3	68.37	3,553	242,918.61
0.44	ENSG	ENSIGN GROUP INC/THE	B1YWPP8	107.25	2,160	231,660.00
0.41	NHC	NATIONAL HEALTHCARE CORP	2139731	76.07	2,857	217,331.99
0.40	HALO	HALOZYME THERAPEUTICS INC	2975098	39.68	5,310	210,700.80
0.40	BKD	BROOKDALE SR	B0PZN33	5.22	40,071	209,170.62
0.39	CSH-U CN	CHARTWELL RETIRE	B8S8C94	7.97	26,035	207,540.22
0.39	SBRA	SABRA HEALTH CAR	B5NLBP6	14.52	14,139	205,298.28
0.38	ACAD	ACADIA PHARMACEU	2713317	22.29	9,100	202,839.00
0.38	GKOS	GLAUKOS CORP	BYMWL19	59.75	3,392	202,672.00
0.38	AMED	AMEDISYS INC	2024332	94.01	2,114	198,737.14
0.37	6600 HK	SCICLONE PHARMAC	BMX5ZW2	1.73	114,300	197,296.42
0.36	ITGR	INTEGER HOLDINGS CORP	BD06LM7	89.29	2,126	189,830.54
0.35	AGL	AGILON HEALTH INC	BLR4TK4	11.33	16,100	182,413.00
0.34	NHI	NATL HEALTH INVESTORS INC	2626125	54.46	3,303	179,881.38
0.34	LIVN	LIVANOVA PLC	BYMT0J1	45.98	3,872	178,034.56
0.32	EKTAB SS	ELEKTA AB-B SHS	B0M42T2	8.48	20,217	171,477.61
0.32	2186 HK	LUYE PHARMA GROUP LTD	BNQ4GF3	0.51	331,324	168,258.10
0.32	8086 JP	NIPRO CORP	6641599	7.71	21,749	167,588.49
0.31	AGIO	AGIOS PHARMACEUTICALS INC	BCBVTX1	22.20	7,429	164,923.80
0.31	GN DC	GN STORE NORD A/S	4501093	22.58	7,167	161,808.07
0.31	SIA CN	SIENNA SENIOR LIVING INC	BWTYXH4	7.91	20,443	161,804.36
0.30	RYM NZ	RYMAN HEALTHCARE LTD	6161525	3.25	49,151	159,777.91
0.30	MMSI	MERIT MEDICAL SYSTEMS INC	2580555	70.53	2,234	157,564.02
0.30	LTC	LTC PROPERTIES INC	2498788	32.44	4,854	157,463.76
0.29	AED BB	AEDIFICA	B1G5XP1	63.85	2,424	154,783.98
0.29	PHM SM	PHARMA MAR SA	BMW2GT8	42.36	3,586	151,920.45
0.28	TBPH	THERAVANCE BIOPHARMA INC	BMNDK09	10.38	14,001	145,330.38
0.27	145720 KS	DENTIUM CO LTD	BF07GJ6	98.94	1,448	143,266.60
0.27	MNKD	MANNKIND CORP	BF081J4	3.50	40,009	140,031.50
0.26	DCPH	DECIPHERA PHARMA	BZ1LFB2	12.19	11,140	135,796.60
0.25	ALEC	ALECTOR INC	BJ4LDC4	5.16	25,316	130,630.56
0.24	1302 HK	LIFETECH SCIENTIFIC CORP	BV9FKS0	0.31	410,292	125,753.15
0.23	DNLI	DENALI THERAPEUTICS INC	BD2B4V0	18.32	6,747	123,605.04
0.23	ATEC	ALPHATEC HOLDINGS INC	BD60BG7	11.71	10,553	123,575.63
0.23	ANGO	ANGIODYNAMICS INC	B00CR04	6.74	17,702	119,311.48
0.23	853 HK	MICROPORT SCIENTIFIC CORP	B676TW7	1.63	72,802	118,943.48
0.21	1789 HK	AK MEDICAL HOLDINGS LTD	BFD6SZ0	0.90	124,189	111,483.11
0.21	1858 HK	BEIJING CHUNLI-H	BVVPXP6	1.76	61,866	109,010.08
0.20	9229 JP	SUNWELS CO LTD	BNTYNB5	16.15	6,644	107,288.83
0.19	EMBC	EMBECTA CORP	BMXWYR1	17.51	5,804	101,628.04
0.17	AMRN	AMARIN CORP PLC -ADR	2301938	0.74	118,249	88,024.56
0.14	2500 HK	VENUS MEDTECH -H	BL6V047	0.72	105,440	75,992.31
0.12	SGHT	SIGHT SCIENCES INC	BN2T5Q6	3.41	18,001	61,383.41
0.11		CASH		1.00	56,489	56,489.08
0.10	CLARI FP	CLARIANE SE	B1HKRM0	2.54	21,365	54,241.85
0.09	NVCR	NOVOCURE LTD	BYSS4X4	12.20	4,093	49,934.60
0.07		OTHER PAYABLE & RECEIVABLES		1.00	36,597	36,597.43
0.06	SILK	SILK ROAD MEDICAL INC	BGHVXJ7	8.09	4,061	32,853.49
0.02	CANO	CANO HEALTH INC	BNV0C14	8.16	1,183	9,656.79
0.01	FGEN	FIBROGEN INC	BSDRYR8	0.46	8,476	3,871.84
0.01		EURO		1.10	2,269	2,491.42
0.00		RADIUS HEALTH INC - CVR	2KFF9T0	0.00	19,104	0.00
0.00		JAPANESE YEN		0.01	-2	-0.01

Holdings are subject to change. "Cash" denotes U.S. dollars.

Exposure As of 10/31/23

	Sector	Weight (%)
	Health Care	92.9
	Real Estate	7.1

Source: new windowAltaVista Research, LLC

	Industry	Weight (%)
	Medical Specialties	33.6
	Pharmaceuticals: Major	24.8
	Biotechnology	21.8
	Real Estate Investment Trusts	7.5
	Pharmaceuticals: Other	7.4
	Medical/Nursing Services	2.9
	Hospital/Nursing Management	1.4
	Electrical Products	0.4
	Telecommunications Equipment	0.2

Source: new windowAltaVista Research, LLC

	Country	Weight (%)
	United States	59.2
	Switzerland	8.3
	Japan	7.9
	Denmark	6.3
	Britain	4.1
	China	4.1
	Ireland	3.1
	South Korea	1.5
	Belgium	1.4
	Australia	0.8
	Germany	0.8
	Other	2.5

Source: new windowAltaVista Research, LLC

All Sector, Industry and Geographic breakdowns, where provided, are based on equity positions held by the ETF and exclude cash, currencies, and other holdings.

ETF Characteristics As of 11/28/23

Return on Equity	12.60%
Weighted Avg. Market Cap	100,295 M
	2022	2023
Price-to-earnings	25.69	26.46
Price-to-book value	3.43	3.26

Source: new windowAltaVista Research, LLC

ETF Risk Stats As of 10/31/23

Versus	Beta
S&P 500	0.68
NASDAQ-100	0.48
MSCI EAFE	0.69
MSCI Emg. Mkts	0.51
Standard Deviation	15.90%

Source: new windowAltaVista Research, LLC

ETF Research

ETF Documents

Latest Premium / Discount As of 11/28/23

NAV	$26.57
Market Price	$26.51
Premium / (Discount)	($0.06)

Current View 2023 Q4 As of 11/28/23

Days at Premium	8
Days at NAV	0
Days at Discount	33
Greatest Premium	0.16%
Greatest Discount	-0.56%

Daily Premium / Discount History As of 11/28/23

Hover over the chart points for details

View Chart Explanation

Download Chart Data (.CSV)

How can the Fund trade at a premium/discount to its NAV?

The primary explanation is that timing discrepancies can arise between the NAV and the trading price of the Fund. Since shares of the Fund trade on the open market, prices are affected by the constant flow of information received by investors, corporations and financial institutions. Depending on how this changing information affects investor sentiment, shares of the Fund may deviate slightly from the value of the Fund's underlying assets. The NAV of the Fund is only calculated once a day (normally at 4:00 p.m. eastern time). As a result, shareholders may pay more than NAV when they buy Fund shares and receive less than NAV when they sell those shares, because shares are purchased and sold at current market prices. However, due to the creation and redemption process that is unique to ETFs, market makers are able to minimize these deviations from NAV by taking advantage of arbitrage opportunities.

What causes these time discrepancies?

Close of Trading Times. Although both the NAV and the daily market price of the Fund are generally calculated based on prices at the closing time of the exchange (generally 4:00 p.m. eastern time), slight differences in this timing may cause discrepancies.

Time of Last Trade. Trading of Global X funds generally takes place during normal trading hours (9:30 a.m. to 4:00 p.m. eastern time). However, it is important to note that the last trade - from which the closing price is determined - may not occur at exactly 4:00 p.m. eastern time. Therefore, changing market sentiment during the time difference may cause the NAV to deviate from the closing price.

International Holdings. The premiums and discounts for funds with significant holdings in international markets may be less accurate due to the different closing times of various international markets. Because the Funds trade during U.S. market hours while the underlying securities may not, the time lapse between the markets can result in differences between the NAV and the trading price.

Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.

AGNG traded under the ticker LNGR from inception until April 1, 2021.

AGNG

Aging Population ETF

Reasons to Consider AGNG

Long-Term Growth Potential

Demographics Drive Consumption

Unconstrained Approach

Key Information As of 11/28/23

ETF Summary

ETF Objective

Trading Details As of 11/28/23

Distributions As of 11/28/23

ETF Prices As of 11/28/23

Performance History

Top Holdings As of 11/28/23

Exposure As of 10/31/23

ETF Characteristics As of 11/28/23

ETF Risk Stats As of 10/31/23

ETF Research

The Genomic Medicine Revolution

ASCO Annual Meeting 2023: Precision Oncology Achieving Widespread Adoption

Diabetes Management: Massive Addressable Market Spurs Innovative Solutions

ETF Documents